{
    "clinical_study": {
        "@rank": "65577", 
        "arm_group": [
            {
                "arm_group_label": "Placebo", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Placebo capsules"
            }, 
            {
                "arm_group_label": "Probiotics", 
                "arm_group_type": "Experimental", 
                "description": "Lactobacillaus Rhamnosus GG 10 billion cfu BID"
            }
        ], 
        "brief_summary": {
            "textblock": "The study will evaluate if administration of probiotic Culturelle (Lactobacillus Rhamnosus\n      GG) along with antibiotics can help decrease the occurrence of diarrhea caused by\n      antibiotics as well as Clostridium difficile Diarrhea."
        }, 
        "brief_title": "Probiotics for Prevention of Antibiotic Associated Diarrhea and Clostridium Difficile Associated Disease in Hospitalized Adults-A Double Blind Placebo Controlled Trial", 
        "completion_date": {
            "#text": "December 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Diarrhea", 
        "condition_browse": {
            "mesh_term": "Diarrhea"
        }, 
        "detailed_description": {
            "textblock": "Inpatient adult males and females who are at least 18 years of age or older, undergoing\n      treatment with antibiotics irrespective of indication and the type of antibiotics. The\n      setting is an academic hospital.The  patients are screened and potentially recruited upon\n      initiation of antibiotic treatment regardless of indication for antibiotic prescription. The\n      participants are patients being admitted to any inpatient units of the hospital for\n      treatment with antibiotics. Exclusion criteria is:\n\n        -  Diarrhea on admission or within the preceding week\n\n        -  Reported recurrent diarrhea\n\n        -  Bowel pathology that could result in diarrhea (including preexisting Inflammatory Bowel\n           disease{IBD}, all forms for colitis or any other condition resulting in preexisting\n           diarrhea)\n\n        -  Intake of high risk antibiotics (clindamycin, cephalosporins, aminopenicillins\u2192 well\n           known to cause CDAD) and or more than two courses of other antibiotics in the past four\n           weeks to exclude pre-existing diarrhea associated with antibiotic use\n\n        -  Immunosuppression (Chronic steroid use, Active chemotherapy, Active radiotherapy, HIV\n           or any other disorder resulting in a compromise in participants immune status)\n\n        -  Bowel surgery causing liquid stools\n\n        -  Regular probiotic intake before admission\n\n        -  Lactose intolerance or intolerance to dairy products."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Inpatient adult males and females who are at least 18-89 years of age,  undergoing\n             treatment with antibiotics irrespective of indication and the type of antibiotics.\n\n        Exclusion Criteria:\n\n          -  Diarrhea on admission or within the preceding week\n\n          -  Reported recurrent diarrhea\n\n          -  Bowel pathology that could result in diarrhea (including preexisting Inflammatory\n             Bowel disease{IBD}, all forms for colitis or any other condition resulting in\n             preexisting diarrhea)\n\n          -  Intake of high risk antibiotics (clindamycin, cephalosporins, aminopenicillins\u2192 well\n             known to cause CDAD) and or more than two courses of other antibiotics in the past\n             four weeks to exclude pre-existing diarrhea associated with antibiotic use\n\n          -  Immunosuppression (Chronic steroid use, Active chemotherapy, Active radiotherapy, HIV\n             or any other disorder resulting in a compromise in participants immune status)\n\n          -  Bowel surgery causing liquid stools\n\n          -  Regular probiotic intake before admission\n\n          -  Lactose intolerance or intolerance to dairy products"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "89 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "290", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "February 25, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02076438", 
            "org_study_id": "Pro2012002450", 
            "secondary_id": "Grant# PC 14-13"
        }, 
        "intervention": {
            "arm_group_label": "Probiotics", 
            "description": "Randomized to receive probiotics or placebo", 
            "intervention_name": "Probiotics", 
            "intervention_type": "Dietary Supplement", 
            "other_name": "Lactobacillus Rhamnosus GG 10 billion cfu bid"
        }, 
        "intervention_browse": {
            "mesh_term": [
                "Anti-Bacterial Agents", 
                "Antibiotics, Antitubercular"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "antibiotics", 
            "diarrhea", 
            "c diff", 
            "Hospitalized patients"
        ], 
        "lastchanged_date": "February 28, 2014", 
        "location": {
            "contact": {
                "email": "aavadhani@saintpetersuh.com", 
                "last_name": "Amita Avadhani, DNP", 
                "phone": "732-745-8600", 
                "phone_ext": "8073"
            }, 
            "contact_backup": {
                "email": "nzaidi@saintpetersuh.com", 
                "last_name": "Naureen Zaidi, BA", 
                "phone": "7327458600", 
                "phone_ext": "8029"
            }, 
            "facility": {
                "address": {
                    "city": "New Brunswick", 
                    "country": "United States", 
                    "state": "New Jersey", 
                    "zip": "08824"
                }, 
                "name": "Saint Peters University Hospital"
            }, 
            "investigator": [
                {
                    "last_name": "David Alcid, MD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Amar Bukhari, MD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Barbara Caldwell, PhD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Mary Kamienski, phD", 
                    "role": "Sub-Investigator"
                }
            ], 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "overall_official": {
            "affiliation": "Rutgers University and Saint Peters University Hospital", 
            "last_name": "Amita Avadhani, DNP", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Diarrhea associated with antibiotics", 
            "measure": "Diarrhea", 
            "safety_issue": "No", 
            "time_frame": "4 weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02076438"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Rutgers, The State University of New Jersey", 
            "investigator_full_name": "Amita Avadhani, DNP, DCC, ACNP, ANP, CCRN", 
            "investigator_title": "Assistant Professor/Track coordinator", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "Patient experience with use of probiotics", 
            "measure": "Tolerability of probiotics", 
            "safety_issue": "No", 
            "time_frame": "4 weeks"
        }, 
        "source": "Rutgers, The State University of New Jersey", 
        "sponsors": {
            "collaborator": {
                "agency": "Saint Peters University Hospital", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "Rutgers, The State University of New Jersey", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "April 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "February 2014"
    }
}